Medharmonia - Company finances
|
EUR
|
2023
From: 2023-03-20
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 3,768 | 13,259 | 19,206 |
| Profit before tax | 929 | -953 | 2,864 |
| Net profit | 929 | -953 | 2,749 |
| Equity | 3,928 | 2,975 | 5,724 |
| Liabilities | 593 | 846 | 964 |
| Non-current assets | 0 | 0 | 0 |
| Current assets | 4,521 | 3,821 | 6,688 |
| Total assets | 4,521 | 3,821 | 6,688 |
|
Taxes paid
|
|||
| STI taxes | 64 | - | 9 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +251.9% | +44.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 20.5% | -24.9% | 41.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 23.7% | -32.0% | 48.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 24.7% | -7.2% | 14.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 24.7% | -7.2% | 14.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.3 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medharmonia - Social security debts
The company had no debts to Sodra
Medharmonia - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medharmonia, MB (code 306276916) is a Small partnership engaged in traditional, complementary and alternative medicine activities. In 2025, the company increased revenue to €19.2K, up 44.9% year on year and 409.7% over two years. Net profit improved to €2.7K, compared with a net loss of €953 in 2024 and net profit of €929 in 2023. The 2025 profit margin was 14.3%, indicating a return to profitability after the weaker result in 2024. The balance sheet also strengthened in 2025: total assets reached €6.7K, equity €5.7K and liabilities €964. Equity represented 85.6% of assets, while the debt-to-equity ratio was 0.17, pointing to a low level of leverage. Return on equity was 48.0% and return on assets 41.1%, supported by an asset turnover of 2.87x. Overall, the 2023–2025 trajectory shows rising turnover, a temporary setback in 2024, and a stronger operating and financial position in 2025.